Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
27,461
archived clinical trials in
Hematology

Therapy of HES, PV, Atypical CML or CMML, and Mastocytosis With Imatinib Mesylate
Therapy of Hypereosinophilic Syndrome, Polycythemia Vera, Atypical CML or CMML With PDGF-R Fusion Genes, or Mastocytosis With Imatinib Mesylate (STI571)
Status: Enrolling
Updated:  6/26/2013
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Therapy of HES, PV, Atypical CML or CMML, and Mastocytosis With Imatinib Mesylate
Therapy of Hypereosinophilic Syndrome, Polycythemia Vera, Atypical CML or CMML With PDGF-R Fusion Genes, or Mastocytosis With Imatinib Mesylate (STI571)
Status: Enrolling
Updated: 6/26/2013
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase II Study of Umbilical Cord Blood Transplantation
A Phase II Study of Umbilical Cord Blood Transplantation Following Myeloablative or Reduced-Intensity Conditioning
Status: Enrolling
Updated:  7/10/2013
Tufts Medical Center
mi
from
Boston, MA
A Phase II Study of Umbilical Cord Blood Transplantation
A Phase II Study of Umbilical Cord Blood Transplantation Following Myeloablative or Reduced-Intensity Conditioning
Status: Enrolling
Updated: 7/10/2013
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Paclitaxel Reduces Effects of Intimal Hyperplasia
Paclitaxel Reduces Effects of Intimal Hyperplasia Status Post Lower Extremity Revascularization
Status: Enrolling
Updated:  7/16/2013
Sanford Vascular Associates
mi
from
Sioux Falls, SD
Paclitaxel Reduces Effects of Intimal Hyperplasia
Paclitaxel Reduces Effects of Intimal Hyperplasia Status Post Lower Extremity Revascularization
Status: Enrolling
Updated: 7/16/2013
Sanford Vascular Associates
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for Steroid-refractory Acute Graft-versus-host Disease
Phase I- II Study of in Vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for the Treatment of Steroid-refractory Acute Graft-versus-host Disease
Status: Enrolling
Updated:  7/17/2013
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for Steroid-refractory Acute Graft-versus-host Disease
Phase I- II Study of in Vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for the Treatment of Steroid-refractory Acute Graft-versus-host Disease
Status: Enrolling
Updated: 7/17/2013
John Theurer Cancer Center at the Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension
Phase 2 Trial for Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension
Status: Enrolling
Updated:  7/29/2013
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension
Phase 2 Trial for Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension
Status: Enrolling
Updated: 7/29/2013
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant
A Phase I Study of the Safety and Feasibility of Azacitidine After Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome After Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated:  8/9/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant
A Phase I Study of the Safety and Feasibility of Azacitidine After Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome After Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated: 8/9/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
A Pilot Study of G-CSF to Disrupt the Bone Marrow Microenvironment in Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
Status: Enrolling
Updated:  8/9/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
A Pilot Study of G-CSF to Disrupt the Bone Marrow Microenvironment in Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma
Status: Enrolling
Updated: 8/9/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV
Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV
Status: Enrolling
Updated:  8/15/2013
NMCSD
mi
from
San Diego, CA
Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV
Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV
Status: Enrolling
Updated: 8/15/2013
NMCSD
mi
from
San Diego, CA
Click here to add this to my saved trials
Radioimmunoimaging of AL Amyloidosis
Radioimmunoimaging (PET/CT) of Patients With AL Amyloidosis Using the 124I-Labeled Amyloid-Reactive Monoclonal Antibody Mu 11-1F4
Status: Enrolling
Updated:  8/21/2013
University of Tennessee Medical Center
mi
from
Knoxville, TN
Radioimmunoimaging of AL Amyloidosis
Radioimmunoimaging (PET/CT) of Patients With AL Amyloidosis Using the 124I-Labeled Amyloid-Reactive Monoclonal Antibody Mu 11-1F4
Status: Enrolling
Updated: 8/21/2013
University of Tennessee Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Radioimmunoimaging of Light Chain (AL) Amyloidosis
Radioimmunoimaging (PET/CT) of Patients With AL Amyloidosis Using the 124I-Labeled Amyloid-Reactive Monoclonal Antibody (mAb) Murine (Mu) 11-F4
Status: Enrolling
Updated:  8/21/2013
University of Tennessee Medical Center
mi
from
Knoxville, TN
Radioimmunoimaging of Light Chain (AL) Amyloidosis
Radioimmunoimaging (PET/CT) of Patients With AL Amyloidosis Using the 124I-Labeled Amyloid-Reactive Monoclonal Antibody (mAb) Murine (Mu) 11-F4
Status: Enrolling
Updated: 8/21/2013
University of Tennessee Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed Refractory Multiple Myeloma
Status: Enrolling
Updated:  9/4/2013
The Cancer Center, Hackensack University Medical Center
mi
from
Hackensack, NJ
A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
A Phase II Study of Bevacizumab and Bortezomib in Patients With Relapsed Refractory Multiple Myeloma
Status: Enrolling
Updated: 9/4/2013
The Cancer Center, Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Status: Enrolling
Updated:  9/25/2013
Rush University Medical Center
mi
from
Chicago, IL
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Status: Enrolling
Updated: 9/25/2013
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Status: Enrolling
Updated:  9/25/2013
University of Kansas Medical Center
mi
from
Kansas City, KA
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Status: Enrolling
Updated: 9/25/2013
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Status: Enrolling
Updated:  9/25/2013
University of Massachusetts
mi
from
Worcester, MA
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Status: Enrolling
Updated: 9/25/2013
University of Massachusetts
mi
from
Worcester, MA
Click here to add this to my saved trials
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Status: Enrolling
Updated:  9/25/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Status: Enrolling
Updated: 9/25/2013
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Status: Enrolling
Updated:  9/25/2013
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Status: Enrolling
Updated: 9/25/2013
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Status: Enrolling
Updated:  9/25/2013
Medical College of Wisconsin/ Froedtert Hospital
mi
from
Milwaukee, WI
Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
A Phase IIb, Multicenter, Open-Label, Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free)for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Status: Enrolling
Updated: 9/25/2013
Medical College of Wisconsin/ Froedtert Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B
Status: Enrolling
Updated:  10/11/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Long Beach, CA
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B
Status: Enrolling
Updated: 10/11/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B
Status: Enrolling
Updated:  10/11/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Washington, DC,
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B
Status: Enrolling
Updated: 10/11/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Washington, DC,
Click here to add this to my saved trials
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B
Status: Enrolling
Updated:  10/11/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Atlanta, GA
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B
Status: Enrolling
Updated: 10/11/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B
Status: Enrolling
Updated:  10/11/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Iowa City, IA
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B
Status: Enrolling
Updated: 10/11/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Iowa City, IA
Click here to add this to my saved trials
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B
Status: Enrolling
Updated:  10/11/2013
Novo Nordisk Clinical Trial Call Center
mi
from
New York, NY
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B
Status: Enrolling
Updated: 10/11/2013
Novo Nordisk Clinical Trial Call Center
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B
Status: Enrolling
Updated:  10/11/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Fort Worth, TX
Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B
An Open-label, Multi-centre, Un-controlled Trial to Assess Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Patients With Haemophilia B
Status: Enrolling
Updated: 10/11/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Viral Kinetics in HCV Clearance in Subjects With Hemophilia
Viral Kinetic Models of HCV Clearance in Hemophiliacs With Telaprevir
Status: Enrolling
Updated:  10/18/2013
University of CIncinnati / Holmes Building
mi
from
Cincinnati, OH
Viral Kinetics in HCV Clearance in Subjects With Hemophilia
Viral Kinetic Models of HCV Clearance in Hemophiliacs With Telaprevir
Status: Enrolling
Updated: 10/18/2013
University of CIncinnati / Holmes Building
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Olive Oil and Cardiovascular Health
Effects of Hydroxytyrosol on Vascular Health
Status: Enrolling
Updated:  11/7/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Olive Oil and Cardiovascular Health
Effects of Hydroxytyrosol on Vascular Health
Status: Enrolling
Updated: 11/7/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty
A Prospective Randomized Trial for the Use of DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty.
Status: Enrolling
Updated:  11/14/2013
Lyndhurst Surgery Center
mi
from
Lyndhurst, OH
DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty
A Prospective Randomized Trial for the Use of DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty.
Status: Enrolling
Updated: 11/14/2013
Lyndhurst Surgery Center
mi
from
Lyndhurst, OH
Click here to add this to my saved trials
PRO#0118: Decitabine Plus Mini Flu-Bu
PRO#0118: A Phase I Study of Decitabin in Combination With Fludarabin and Busulfan as a Reduced Intensity Conditioning Regimen for the Treatment of Myeloid Malignancies
Status: Enrolling
Updated:  11/18/2013
Hackensack University Medical Center - John Theurer Cancer Center
mi
from
Hackensack, NJ
PRO#0118: Decitabine Plus Mini Flu-Bu
PRO#0118: A Phase I Study of Decitabin in Combination With Fludarabin and Busulfan as a Reduced Intensity Conditioning Regimen for the Treatment of Myeloid Malignancies
Status: Enrolling
Updated: 11/18/2013
Hackensack University Medical Center - John Theurer Cancer Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Huntsville, AL
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Phoenix, AZ
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
San Diego, CA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Colorado Springs, CO
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
New London, CT
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
New London, CT
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Boynton Beach, FL
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcottt Investigational Study Site
mi
from
Clearwater, FL
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcottt Investigational Study Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Atlanta, GA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Coeur d'Alene, ID
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Coeur d'Alene, ID
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Chicago, IL
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Site
mi
from
Granger, IN
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Site
mi
from
Granger, IN
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
West Des Moines, IA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Overland Park, KA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Marrero, LA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Marrero, LA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Elkridge, MD
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Elkridge, MD
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Brookline, MA
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Brookline, MA
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Omaha, NE
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Omaha, NE
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Las Vegas, NV
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Moorestown, NJ
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Moorestown, NJ
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Albuquerque, NM
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Purchase, NY
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Purchase, NY
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Greensboro, NC
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Greensboro, NC
Click here to add this to my saved trials
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated:  11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Cleveland, OH
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
A Study to Assess the Safety and Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
Status: Enrolling
Updated: 11/21/2013
Warner Chilcott Investigational Study Site
mi
from
Cleveland, OH
Click here to add this to my saved trials